Ligand Pharmaceuticals | LGND - 销售成本



金融业
股票价格
USD
资产
USD 1.56B
现金及等价物
USD 174.93M
销售成本
USD 11.9M
流动资产
USD 832.27M
流动负债
USD 37.45M
债务
USD 451M
EBIT
USD 158.89M
EBITDA
USD 150.32M
员工
68
EPS每股收益
USD 2.02
股本和储备
USD 1.02B
销售毛利
USD 155.28M
债务利息支出
USD 910K
利息收入
USD 3.87M
贷款资金
USD 445.49M
市值
USD 4.04B
净收入
USD 117.27M
营业费用
USD 8.29M
营业利润
USD 158.89M
普通股股本
USD 19.66M
PE价格收益
60.65
税前利润
USD 141.14M
销售收入
USD 59.66M
销售和管理费用
USD 28.45M
股票
USD 9.13M
贸易债权人
USD 3.24M
应收帐款人
USD 58.1M


销售成本 更改 日
Agenus USD 642K 399K 2025-09
Amgen USD 1.6B 187M 2026-03
Anika Therapeutics USD 11.44M 797K 2025-12
Baxter International USD 1.81B 587M 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Eli Lilly USD 3.58B 205M 2026-03
Enviri Corporation USD 472M 17.65M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
Glaxosmithkline GBP 3.47B 461.37M 2025-12
Heron Therapeutics USD 11.12M 795K 2025-12
Insmed USD 46.16M 15.25M 2025-12
Intrexon USD 1.01M 344K 2024-06
Ionis Pharmaceuticals USD 3M 5M 2026-03
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Ligand Pharmaceuticals USD 11.9M 733K 2025-09
MacroGenics USD 10.12M 34.18M 2025-12
Merck USD 2.94B 380M 2026-03
Pacira USD 50.74M 3.89M 2026-03
Pfizer USD 6.29B 2.12B 2025-12
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
Veracyte USD 39.28M 1.93M 2025-12